Podcasts about Hoskins

Send us a textIn this episode of Getting Real with John Natale, John interviews one of Indiana's fastest-rising real estate professionals, Kati Hoskins.Kati has grown a following of over 15,000 on Instagram, 2,000 on Facebook, 5,500 on TikTok and 4,200 subscribers on YouTube..all within the last six months.It's exploded her business as a third year agent. She's gone all in and won.Kati shares her powerful story and what drives her to succeed.She provides tactical advice to not only grow your brand, but also your business.A must listen interview with John Natale & Kati Hoskins.If you'd like to learn more about John and his mission to redesign the real estate industry, click the link here: https://natalecoaching.com/You can also book a 1:1 Coaching Discovery Call with John.Connect with John on Socials:TikTokInstagramYouTube30 Day Free Trial of Seller Leads: MyPlus LeadsLooking for a great AI CRM? Check out ZappREInterested in joining Natale Realtors? Click Here

THE PARK IS NOW OPEN!! Jurassic World Full Reaction Watch Along:   / thereelrejects   Visit https://huel.com/rejects to get 15% off your order What A Fun Monster Movie! Jurassic World Reaction, Recap, Commentary, Analysis, & Spoiler Review!! Greg Alba and Tara Erickson react to the massive 2015 blockbuster Jurassic World, the fourth film in the Jurassic Park franchise! Starring Chris Pratt (Guardians of the Galaxy, The Super Mario Bros. Movie) as Owen Grady, Bryce Dallas Howard (Spider-Man 3, The Help) as Claire Dearing, Vincent D'Onofrio (Daredevil, Full Metal Jacket) as Hoskins, Ty Simpkins (Iron Man 3, Insidious) as Gray, and Nick Robinson (Love, Simon, Everything, Everything) as Zach, the film brought the park back to life in a massive way. We go deep into the best Jurassic World moments including the Indominus Rex escape, the Velociraptor squad hunting sequence, and the epic T-Rex vs Indominus Rex final battle — some of the most viewed scenes on YouTube like "T-Rex and Blue vs Indominus Rex" (200M+ views), “Mosasaurs Eats Shark” (100M+), and “Indominus Rex Kills Ankylosaurus.” Featured dinosaurs include the fan-favorite Velociraptor, Tyrannosaurus Rex (T-Rex), Mosasaurus, Indominus Rex, Triceratops, Ankylosaurus, Apatosaurus, and Pteranodons. We also cover how Jurassic World fits into the full Jurassic Park franchise timeline, following Jurassic Park (1993), The Lost World: Jurassic Park (1997), Jurassic Park III (2001), Jurassic World (2015), Jurassic World: Fallen Kingdom (2018), and Jurassic World Dominion (2022). Does Jurassic World hold up nearly a decade later? How does the film balance legacy nostalgia with new thrills? Let's find out together in this hilarious, geeky, and emotional revisit. Don't forget to like, comment with your favorite dinosaur, and subscribe for more blockbuster movie reactions! Follow Tara Erickson: Youtube: https://www.youtube.com/@TaraErickson Instagram:  https://www.instagram.com/taraerickson/ Twitter:  https://twitter.com/thetaraerickson Intense Suspense by Audionautix is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/... Support The Channel By Getting Some REEL REJECTS Apparel! https://www.rejectnationshop.com/ Follow Us On Socials:  Instagram: https://www.instagram.com/reelrejects/  Tik-Tok: https://www.tiktok.com/@reelrejects?lang=en Twitter: https://x.com/reelrejects Facebook: https://www.facebook.com/TheReelRejects/ Music Used In Ad:  Hat the Jazz by Twin Musicom is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/ Happy Alley by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/... POWERED BY @GFUEL Visit https://gfuel.ly/3wD5Ygo and use code REJECTNATION for 20% off select tubs!! Head Editor: https://www.instagram.com/praperhq/?hl=en Co-Editor: Greg Alba Co-Editor: John Humphrey Music In Video: Airport Lounge - Disco Ultralounge by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/ Ask Us A QUESTION On CAMEO: https://www.cameo.com/thereelrejects Follow TheReelRejects On FACEBOOK, TWITTER, & INSTAGRAM:  FB:  https://www.facebook.com/TheReelRejects/ INSTAGRAM:  https://www.instagram.com/reelrejects/ TWITTER:  https://twitter.com/thereelrejects Follow GREG ON INSTAGRAM & TWITTER: INSTAGRAM:  https://www.instagram.com/thegregalba/ TWITTER:  https://twitter.com/thegregalba Learn more about your ad choices. Visit megaphone.fm/adchoices

The people of the Holy Spirit - Rachel Hoskins by

After the WIP Midday Show talked about a potential Rhys Hoskins return on Friday, Hoskins proceeded to have several great performances including a 2 home run game! Well that mixed with a quote Bryce Harper put out to the media have only added to the rumors of a Rhys Hoskins return!

The 94 WIP Crew, Joe DeCamara, Jon Ritchie, Joe Giglio, Hugh Douglas, Spike Eskin, Ike Reese, and Jack Fritz all sound off on the state of the Phillies as they face off against the Brewers and former Phillies Outfielder Rhys Hoskins, as the Midday show checks in on the status of Andrew Painter. Don't miss out on all the Phillies buzz this week on 94 WIP! Tune in weekdays 6 AM - 6 PM EST on 94 WIP, the Audacy app, or tune into the YouTube livestream at YouTube.com/@SportsRadio94WIP

The 94 WIP Crew, Joe DeCamara, Jon Ritchie, Joe Giglio, Hugh Douglas, Spike Eskin, Ike Reese, and Jack Fritz all sound off on the state of the Phillies as they face off against the Brewers and former Phillies Outfielder Rhys Hoskins, as the Midday show checks in on the status of Andrew Painter. Don't miss out on all the Phillies buzz this week on 94 WIP! Tune in weekdays 6 AM - 6 PM EST on 94 WIP, the Audacy app, or tune into the YouTube livestream at YouTube.com/@SportsRadio94WIP

The 94 WIP Crew, Joe DeCamara, Jon Ritchie, Joe Giglio, Hugh Douglas, Spike Eskin, Ike Reese, and Jack Fritz all sound off on the state of the Phillies as they face off against the Brewers and former Phillies Outfielder Rhys Hoskins, as the Midday show checks in on the status of Andrew Painter. Don't miss out on all the Phillies buzz this week on 94 WIP! Tune in weekdays 6 AM - 6 PM EST on 94 WIP, the Audacy app, or tune into the YouTube livestream at YouTube.com/@SportsRadio94WIP

The Hoskins sing "No Regrets" during a worship service at Immanuel Baptist Church, Florence, Ky. Please visit us at 7183 Pleasant Valley Road Florence KY 41042, or call us at (859) 586-6829. Church links: Website: https://www.ibcflorence.com Daily Devotions: https://www.ibcflorence.com/devotions Free App: http://www.ibcflorence.com/ibc-app Our entire list of recent sermons: https://www.ibcflorence.com/recent-sermons Youtube: https://www.youtube.com/ibcflorence Facebook: https://www.facebook.com/ibcflorenceky Instagram: https://www.instagram.com/ibcflorence/ Podcasts: https://soundcloud.com/user-658781358 Live Stream: https://www.youtube.com/ibcflorence/live We would love to know how to pray for you! Romans 10:9 #ibcflorence #florenceky #kjvBible #church #Godisgood #northernkentucky #baptistchurch #savedbygrace #video

The Hoskins sing "The Greatest Thing" during a worship service at Immanuel Baptist Church, Florence, Ky. Please visit us at 7183 Pleasant Valley Road Florence KY 41042, or call us at (859) 586-6829. Church links: Website: https://www.ibcflorence.com Daily Devotions: https://www.ibcflorence.com/devotions Free App: http://www.ibcflorence.com/ibc-app Our entire list of recent sermons: https://www.ibcflorence.com/recent-sermons Youtube: https://www.youtube.com/ibcflorence Facebook: https://www.facebook.com/ibcflorenceky Instagram: https://www.instagram.com/ibcflorence/ Podcasts: https://soundcloud.com/user-658781358 Live Stream: https://www.youtube.com/ibcflorence/live We would love to know how to pray for you! Romans 10:9

The Phillies open a three-game series on Friday night against the Brewers, so we thought it'd be a great time to catch up with Rhys Hoskins.Hoskins talked about his resurgence at the plate this season with Milwaukee, playing for Phillies manager Rob Thomson and Brewers manager Pat Murphy and his most memorable moments with the Phillies, including the iconic bat spike in the 2022 NLDS, the Mets, his home-run celebration and more!They say Delco's a lot … and they're right. Find a full list of weekend events at VisitDelco.com, including the Tyler Arboretum's Family Explorers: Animal All-Stars event on Saturday and the Ciao Delco Annual Italian American Festival on Sunday at Rose Tree Park!Get 20% off your first Slab Pack or card purchase by going to ArenaClub.com/FOUL and use code FOUL.Love The Phillies Show? You can purchase your very own Phillies Show t-shirt by 47 Brand here! We've got maroon and powder blue shirts in stock!@The Phillies Show Subscribe to the show on YouTube and follow us on social media!@Foul Territory We're part of the Foul Territory Network. Follow FT and find more shows, including Fair Territory!If you like The Phillies Show, subscribe and give us a five-star review!

On today's show, the WIP Midday Show want to bring former first baseman Rhys Hoskins back! They believe it can bolster the Phillies bats without relinquishing too much in the field! Would you be happy if the Phillies brought back Hoskins? Also, new updates on the Bryce Harper injury from manager Rob Thomson! Plus, the midday show is joined by Scott Franzke to break down this week's series vs the Braves and preview the series with the Brewers. And, Eliot Shorr-Parks joins the show to break down the first week of Eagles OTA's. As well as an update in the Kyle Schwarber contract situation, checking in on pitching prospect Andrew Painter, Bryce Huff getting traded to the 49ers and more!

Continuing the conversation of bring Rhys Hoskins back to Philly. The WIP Midday Show talks about how well Hoskins would slot into the Phillies lineup! As well as improving a specific area that the Phillies have struggled at the plate this year!

Special Guest (maybe soon to be co-host) Andrew Hoskins joins the podcast to discuss driving to a football game in another city, the new CFL rules applications with emphasis on getting tougher on rough play calls, and Andrew discusses the growth of flag-football, its adoption into the LA Olympics, and what the furture impact is for tackle football as a result.  (CFL on CBC theme music used with express written permission; podcast recorded May 22, 2025).

As followers of Jesus we are called to be salt and light to the world. Salt cannot lose it's saltiness but can be affected by dilution or contamination. We are to be selective of the company we keep, as well as eradicate any compromise in our lives. The way we live matters, along with the ability to share our testimonies well.

Phillies players have been talking about a certain former member of the clubhouse recently. It's now Brewers first baseman Rhys Hoskins! The WIP Midday Show reacts to what some of the players had to say and if it may be worth it to bring Hoskins back to Philadelphia?

New @InThisLeaguePod Fantasy Baseball Podcast with @BogmanSports and @IsItTheWelsh➡️ Savant's new attack angle information➡️ You believe in Will Benson?➡️ Is Will Warren a must pick up?➡️ Hoskins, Baldwin, L. Henderson and more!Join up to be a member of the army and support your boys to create more and more fantasy Baseball content that not only wins your league, but makes you laugh! Redraft ranks, prospect/dynasty ranks, groupme rooms, live podcasts and more! Find it all at inthisleague.comFollow the guys on Twitter @IsItTheWelsh  @BogmanSports

Following two ugly losses to the red hot Twins, Jackson Chourio's glove saved a Sunday win. Hoskins, Contreras, Henderson, and Uribe highlighted a three game win streak during the week before failing to sweep the Orioles yesterday. At just 24-26, they failed to reach .500 again, heading into Pittsburgh.Use the code "SCOOP20" at shockersbaseball.org for 20% off of private pitching, hitting, catching, or infield lessons!Music from #Uppbeat (free for Creators!):https://uppbeat.io/t/mountaineer/gotchaLicense code: 8X4AOGJBECIWVDS3

Andew Hoskins joins to discuss CFL training camps, whether Zach Collaros should have had a certain phone number in his contact list, the elks new staff making an impression in Edmonton, and the depth of quarterbacks in th CFL for 2025.  (CFL on CBC theme music used with written permission; podcast recorded May 12, 2025).

A judge has ruled Erik and Lyle Menendez will have a new shot at freedom after 35 years behind bars; Olympic cyclist Rohan Dennis has received a suspended sentence over the death of his wife, fellow Olympian Melissa Hoskins; Liberal women are rallying behind the federal party's first female leader, branding questions about her ascension as sexist; Bindi Irwin is "on the road to recovery" after having her appendix and 14 endometriosis lesions removed during emergency surgery. The Quicky is the easiest and most enjoyable way to get across the news every day. And it’s delivered straight to your ears in a daily podcast so you can listen whenever you want, wherever you want...at the gym, on the train, in the playground or at night while you're making dinner. Support independent women's media CREDITS Host: Nicole Madigan Audio Producer: Lu HillBecome a Mamamia subscriber: https://www.mamamia.com.au/subscribeSee omnystudio.com/listener for privacy information.

The first quarter of the #MilwaukeeBrewers season is already in the books! What grades would you give the team? Certain players? Plus we chat Tobias, Woodruff, Hoskins, and more! #Brewers See omnystudio.com/listener for privacy information.

The Brewers went 5-2 in San Francisco and St. Louis to drop to third in the NL Central. Jose Quintana was great twice, but can the pitching staff weather the storm as the bullpen has struggled?Use the code "SCOOP20" at shockersbaseball.org for 20% off of private pitching, hitting, catching, or infield lessons!Music from #Uppbeat (free for Creators!):https://uppbeat.io/t/mountaineer/gotchaLicense code: 8X4AOGJBECIWVDS3

In this episode of the Econ Dev Show, host Dane Carlson sits down with Victor Hoskins, President and CEO of Fairfax County Economic Development Authority, who oversees Virginia's largest economy and leads a team that has secured approximately $3 billion in capital investment. Victor shares insights from his unique career spanning both public and private sectors, including his instrumental role in securing Amazon HQ2 during his time at Arlington Economic Development. With candid reflections on his education at MIT, experience in private equity, and passion for creating economic opportunity, Victor reveals his philosophy that has helped companies create over 38,000 jobs in Fairfax County – a place he describes as "where companies come to dent the universe." Like this show? Please leave us a review here (https://econdevshow.com/rate-this-podcast/) — even one sentence helps! Special Guest: Victor Hoskins.

Jack continues his conversations on aviation with pilot and educator Nathan Hoskins about how you can earn your drone pilots license. See omnystudio.com/listener for privacy information.

En el día de hoy: Aaron Judge guía la barrida de los Yankees con su 7mo jonrón de la temporada. Shohei Ohtani pega cuadrangular tempranero y Dodgers barren a los Rockies. Vladimir Guerrero Jr. conecta su primer jonrón del año y Chris Bassitt domina en victoria de Toronto. Ty France deja en el terreno a Mets en extrainnings, y Lindor será el capitán de Puerto Rico en el Clásico Mundial 2026. Jackson Holliday conecta Grand Slam y Orioles siguen encendidos. Dbacks apalean a Marlins con 4 jonrones, incluido uno de Gurriel Jr. Cerveceros vencen a Tigres con joya de José Quintana y batazos de Yelich, Freilick y Hoskins. ¡No olvides suscribirte y activar la campanita para no perderte ningún episodio de Baseball News! #MLB #Yankees #Dodgers #Ohtani #VladimirGuerreroJr #FranciscoLindor #BaseballNews #ClásicoMundial #Orioles #Mets #MLBHighlightsConviértete en un seguidor de este podcast: https://www.spreaker.com/podcast/con-las-bases-llenas-podcast-de-beisbol--2742086/support.

Grant reacts to the Brewers winning the series over DET and talks about the addition of Quinn Priester and the production of Yelich and Hoskins. Bart Winkler joins talk NBA playoffs and NFL draft, and Jesse Temple talks Badgers. See omnystudio.com/listener for privacy information.

¡Bienvenidos a Baseball News! Hoy te traemos lo más destacado del mundo de las Grandes Ligas: Jasson Domínguez brilla con noche perfecta y guía remontada de los Yankees ante los Royals. Padres caen por primera vez en casa tras hit clave de Nico Hoerner para los Cubs. Alex Bregman se va de 5-5 con 4 impulsadas en victoria de Boston sobre los Rays. Harper y Realmuto lideran a Phillies frente a los Gigantes. Austin Hays tiene debut soñado con Rojos ante Mariners. Astros blanquean a los Cardenales con joya de Hunter Brown. Rhys Hoskins y los Cerveceros pintan de blanco a los Tigres.

Evelyn Hoskins speaks exclusively to West End Frame about reprising her performance as Carol in the North American premiere of 42 Balloons at the Chicago Shakespeare Theater.Evelyn co-hosted last week's episode of The West End Frame Show and whilst she was in the podcast booth she spoke about taking 42 Balloons' to the US. We couldn't include that bit of the conversation in last week's episode as the casting news hadn't been revealed... but now that it's all announced, in this mini episode we bring you the clip of Evelyn discussing how she feels about returning to 42 Balloons for its North American premiere alongside Charlie McCullagh as Larry.Last year Evelyn starred as Carol in the fully staged premiere of 42 Balloons at The Lowry in Salford, having played the role for the concert performances at the Vaudeville Theatre. The show is written by Jack Godfrey and directed by Ellie Coote.42 Balloons runs at Chicago Shakespeare Theatre 24th May – 29th June 2025. Visit www.chicagoshakes.com for info and tickets. Follow Evelyn on Instagram: @evelynhoskins This podcast is hosted by Andrew Tomlins. @AndrewTomlins32 Thanks for listening!Email: andrew@westendframe.co.ukVisit westendframe.co.uk for more info about our podcasts. Hosted on Acast. See acast.com/privacy for more information.

The Milwaukee Brewers young players are carrying the team right now. Sal Frelick, Brice Turang, and Jackson Chourio are carrying the Brewers offense while Yelich, Contreras, and Hoskins find their offense. I also ripped into the Pirates management for some choices they have made during the course of the past week. and finally, Giannis is the MVP. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit sportsthoughtsfromevan.substack.com

Fantasy Baseball Live – April 6, 2025Segment 1 and 2 - Review the weekend gamesAdditional Questions1.Chase Dollander gets the call and pitches today…well, now.2.Sugano had a solid outing on Saturday. 5.1 IP, 5 hit, 1 hit, 4K/1BBa.Jackson Holiday, with three more hits, is now hitting .333. Much better than last season!3.There was no love for Eduardo Rodriguez entering this season and while he gave up four runs in five innings to the Nationals, he also struck out 12.a.Thoughts on E-Rod for the season?4.Matthew Boyd had a great outing on Saturday. 6.0 IP, 5 hits, 0 ER, 5K/1BB5.The Brewers have struggled to score runs this season. Yelich is batting .107, Contreras .0978, and Hoskins .136. Somehow, they are 4-5 entering Sunday's game.6.The Braves finally won on Friday, but after Saturday's loss, they are 1-8. They overachieved with Acuna last season. Are they underachieving so far in 2025?7.Tanner Bibee got rocked by the Angels of all teams.8.Jesse Winker went 2 for 4 with two triples. Kind of a weird stat line. Winker, in my view, is sneaky good as a fifth outfielder, but I don't think the Mets agree as he's clearly in a platoon role at DH with Starling Marte.Segment 3 – Waiver WireSegment 4 – Closer ReportClose

Some days life can feel hard. We can face a lot of challenges — at home, work, in our relationships and everything in between. So, how can we stay calm, grounded and in alignment when we feel stretched too thin, and out of our comfort zone? Come listen to my conversation with clinical nutritionist and herbalist Jessica Hoskins, who shares simple, science-backed strategies you can implement today. If you're feeling like life is just too much right now, you don't want to miss this episode. Listen now to regain balance with your nervous system, and get your life back on track. >> Join A New Interior Styling Training: Learn How To Style Like An Expert >> Click here to register now: https://www.nataliewalton.com/confident >> Want to thrive in your creative business? Come join Design & Grow and take advantage of a new & exciting offer. Click here to get started today: www.nataliewalton.com/grow >> Ready to take your interiors to the next level? Join The Styling Masterclass now: www.nataliewalton.com/thestylingmasterclass ~ Let's connect! Instagram: instagram.com/nataliewalton Website: nataliewalton.com Download Your Essential Guide to Style with Clarity & Confidence: nataliewalton.com/handbook Get Your FREE Step by Step Plan to Design & Grow Your Dream Creative Business: nataliewalton.com/thrive  Access Podcast Shownotes: www.nataliewalton.com/podcast Take the Podcast Survey: www.nataliewalton.com/podcastsurvey   

Evelyn Hoskins (42 Balloons / Spring Awakening) returns to co-host The West End Frame Show!Andrew and Evelyn discuss Six In Cinemas and Retrograde (Apollo Theatre) as well as all the latest news from this year's Olivier Awards... and lots more along the way!Evelyn starred as Thea in the original London production of Spring Awakening at the Lyric Hammersmith and in the West End. She recently reunited with the original cast for a reunion concert at the Victoria Palace Theatre which she also co-produced. Last year Evelyn starred as Carol in the fully staged premiere of 42 Balloons at The Lowry in Salford, having played the role for the concert performances at the Vaudeville Theatre. Evelyn's other theatre credits include: Wendy in Peter Pan (US Tour), the title role in Carrie (Southwark Playhouse), Maureen in Mrs Henderson Presents (Toronto), Dawn in Waitress (West End / UK Tour), Louise in Gypsy (Mill At Sonning), Tatiana in Spies Are Forever In Concert (Gillian Lynne Theatre) and Portia in Something Rotten In Concert (Theatre Royal Drury Lane). In addition to playing Liesl in The Sound of Music LIVE (ITV), Evelyn has worked extensively on screen. Follow Evelyn on Instagram: @evelynhoskins This podcast is hosted by Andrew Tomlins. @AndrewTomlins32 Thanks for listening!Email: andrew@westendframe.co.ukVisit westendframe.co.uk for more info about our podcasts. Hosted on Acast. See acast.com/privacy for more information.

What if I told you that the only limits in life are the ones you put on yourself? In today's episode, I'm sitting down with Keaton “The Muscle” Hoskins, a guy who's built 22 businesses, scaled to eight figures, and is on a mission to prove that success has no ceiling.Keaton's got an insane track record, but what's even more impressive is how he thinks. He's not just about making money, he's about helping others break past their own limitations. We dive into what it really takes to build wealth, whether it's smarter to start or buy a business, and why so many entrepreneurs stay stuck when they don't have to.We also talk about seller financing, scaling strategies, and why most people overcomplicate success. Keaton shares his thoughts on abundance vs. scarcity mindsets, overcoming fear, and the one skill every entrepreneur needs to master next.If you're ready to think bigger, take action, and stop putting limits on your potential, this is the episode for you.Get access to our real estate community, coaching, courses, and events at Wealthy University https://www.wealthyuniversity.com/Join our FREE community, weekly calls, and bible studies for Christian entrepreneurs and business people. https://www.wealthykingdom.com/ If you want to level up, text me at 725-527-7783!--- About Ryan Pineda: Ryan Pineda has been in the real estate industry since 2010 and has invested in over $100,000,000 of real estate. He has completed over 700 flips and wholesales, and he owns over 650 rental units. As an entrepreneur, he has founded seven different businesses that have generated 7-8 figures of revenue. Ryan has amassed over 2 million followers on social media and has generat...

Sue Stockdale talks to Rosemary Hoskins, a learning and development expert, about navigating uncertainty in careers, personal growth, and leadership. Rosemary shares her journey from graduating during a recession to building a diverse career and offers insights on the importance of critical thinking, adaptability, and peer learning. The conversation emphasizes the value of evaluating risks, asking 'what if' questions, and creating plans to manage the unknown. Rosemary also talks about her unique personal experiences, including bringing a polo pony from Argentina and building her own ecohouse illustrating the power of stepping out of one's comfort zone to explore opportunities.About Rosemary HoskinsRosemary Hoskins has built her career in people development around designing and leading strategic change to enhance organisational capability and to change the way that people work. Most recently serving as Global Capability Lead at AstraZeneca, she has previously worked in learning and development roles at Barclays, Citi, BP, UKTI, and PA Consulting.  Her first career was as an independent environmental consultant.  She likes to learn things mainly through doing them, supported by sharing ideas with others and just the right amount of relevant content.  Connect with Rosemary Hoskins on LinkedInTime Stamps01:57 Rosemary's Early Career Challenges04:04 Skills for Thriving in Uncertainty05:34 The Role of AI in Critical Thinking06:57 Working in the Grey08:37 Learning and Development Strategies09:55 Personal Stories and Career Reflections10:42 The Polo Pony Adventure17:33 Leadership and Peer Support20:04 Future Outlook and Final ThoughtsConnect with Access to Inspiration: Twitter | Facebook | Instagram | LinkedIn | Read our Impact Report and if you would like to support us then Buy Me A CoffeeProducer: Sue Stockdale   Sound Editor: Matias De Ezcurra Become a supporter of this podcast: https://www.spreaker.com/podcast/access-to-inspiration--4156820/support.

March 30, 2025 - Sunday Evening with Pastor Todd Hoskins

My guest this week is Christy Haskins, the VP and CMO of La-Z-Boy, leading the brand reinvigoration efforts of the nearly 100-year-old—yes, 100!—beloved brand across consumer marketing, digital commerce, consumer insights, and creative. Previously, Christy worked across brands and portfolios at Whirlpool Corporation and Nestlé Purina PetCare. Her experience spans brand management, shopper and retail marketing, innovation, and category management across well-known brands like KitchenAid, Whirlpool, Beautiful, and Veega.

PWG sits down with Denny Hoskins, the newly elected Missouri Secretary of State to review his plans for election integrity in the Show-Me-State. Also joining us is Mark Cook, a cyber election ecosystem expert who shows how same day, paper ballot, hand filed and hand counting ballots is less expensive and cannot be rigged.Keep up with these fellas at:Denny Hoskins: Denny.Hoskins@SOS.Mo.govMark Cook:https://HandcCountRoadShow.org----------------------------Check out all of our vendors at: https://patriotswithgrit.com/patriot-partners/ SPONSORS FOR THIS VIDEO❤️ Cardio Miracle - Boost your energy, help support your immune system, and improve your mental clarity-plus use promo code GRIT and save 10% on your order https://cardiomiracle.myshopify.com/discount/GRIT➡️ RNC Store- Immunity is your first line of defense and laetrile/B17 from Richardson Nutritional Center can provide you with natural health supplements to improve your wellness. - Use promo code GRIT and save 10% on your order https://rncstore.com/GRIT

Jack and Spencer discuss the hot spring training performances of Christian Yelich and Rhys Hoskins, the current state of the infield mix, and more.

Dr. Ebony Hoskins and Dr. Andreas Obermair discuss the surgical management of gynecologic cancers, including the role of minimally invasive surgery, approaches in fertility preservation, and the nuances of surgical debulking. TRANSCRIPT Dr. Ebony Hoskins: Hello and welcome to the ASCO Daily News Podcast, I'm Dr. Ebony Hoskins. I'm a gynecologic oncologist at MedStar Washington Hospital Center in Washington, DC, and your guest host of the ASCO Daily News Podcast. Today we'll be discussing the surgical management of gynecologic cancer, including the role of minimally invasive surgery (MIS), approaches in fertility preservation, and the nuances of surgical debulking, timing, and its impact on outcomes. I am delighted to welcome Dr. Andreas Obermair for today's discussion. Dr. Obermair is an internationally renowned gynecologic oncologist, a professor of gynecologic oncology at the University of Queensland, and the head of the Queensland Center for Gynecologic Cancer Research. Our full disclosures are available in the transcript of this episode. Dr. Obermair, it's great speaking with you today. Dr. Andreas Obermair: Thank you so much for inviting me to this podcast. Dr. Ebony Hoskins: I am very excited.  I looked at your paper and I thought, gosh, is everything surgical? This is everything that I deal with daily in terms of cancer in counseling patients. What prompted this review regarding GYN cancer management? Dr. Andreas Obermair: Yes, our article was published in the ASCO Educational Book; it is volume 44 in 2024. And this article covers some key aspects of targeted precision surgical management principles in endometrial cancer, cervical cancer, and ovarian cancer. While surgery is considered the cornerstone of gynecologic cancer treatment, sometimes research doesn't necessarily reflect that. And so I think ASCO asked us to; so it was not just me, there was a team of colleagues from different parts of the United States and Australia to reflect on surgical aspects of gynecologic cancer care and I feel super passionate about that because I do believe that surgery has a lot to offer. Surgical interventions need to be defined and overall, I see the research that I'm doing as part of my daily job to go towards precision surgery. And I think that is, well, that is something that I'm increasingly passionate for. Dr. Ebony Hoskins: Well, I think we should get into it. One thing that comes to mind is the innovation of minimally invasive surgery in endometrial cancer. I always reflect on when I started my fellowship, I guess it's been about 15 years ago, all of our endometrial cancer patients had a midline vertical incision, increased risk of abscess, infections and a long hospital stay. Do you mind commenting on how you see management of endometrial cancer today? Dr. Andreas Obermair: Thank you very much for giving the historical perspective because the generation of gynecologic oncologists today, they may not even know what we dealt with, what problems we had to solve. So like you, when I was a fellow in gynecologic oncology, we did midline or lower crosswise incisions, the length of stay was, five days, seven days, but we had patients in hospital because of complications for 28 days. We took them back to the operating theaters because those are patients with a BMI of 40 plus, 45, 50 and so forth. So we really needed to solve problems. And then I was exposed to a mentor who taught minimal invasive surgery. And in Australia he was one of the first ones who embarked on that. And I can remember, I was mesmerized by this operation, like not only how logical this procedure was, but also we did rounds afterwards. And I saw these women after surgery and I saw them sitting upright, lipstick on, having had a full meal at the end of the day. And I thought, wow, this is the most rewarding experience that I have to round these patients after surgery. And so I was thinking, how could I help to establish this operation as standard? Like a standard that other people would accept this is better. And so I thought we needed to do a trial on this. And then it took a long time. It took a long time to get the support for the [LACE - Laparoscopic Approach to Cancer of the Endometrium] trial. And in this context, I just also wanted to remind us all that there were concerns about minimal invasive surgery in endometrial cancer at the time. So for example, one of the concerns was when I submitted my grant funding applications, people said, “Well, even if we fund you, wouldn't be able to do this trial because there are actually no surgeons who actually do minimally invasive surgery.” And at the time, for example, in Australia, there were maybe five people, a handful of people who were able to do this operation, right? This was about 20 years ago. The other concern people had was they were saying, could minimally invasive surgery for endometrial cancer, could that cause port side metastasis because there were case reports. So there were a lot of things that we didn't know anyway. We did this trial and I'm super happy we did this trial. We started in 2005, and it took five years to enroll. At the same time, GOG LAP2 was ramping up and the LACE trial and GOG LAP2 then got published and provided the foundations for minimally invasive surgery in endometrial cancer. I'm super happy that we have randomized data about that because now when we go back and now when people have concerns about this, should we do minimally invasive surgery in P53 mutant tumors, I'm saying, well, we actually have data on that. We could go back, we could actually do more research on that if we wanted to, but our treatment recommendations are standing on solid feet. Dr. Ebony Hoskins: Well, my patients are thankful. I see patients all the time and they have high risk and morbidly obese, lots of medical issues and actually I send them home most the same day. And I think, you know, I'm very appreciative of that research, because we obviously practice evidence-based and it's certainly a game changer. Let's go along the lines of MIS and cervical cancer. And this is going back to the LACC [Laparoscopic Approach to Cervical Cancer] trial.  I remember, again, one of these early adopters of use of robotic surgery and laparoscopic surgery for radical hysterectomy and thought it was so cool. You know, we can see all the anatomy well and then have the data to show that we actually had a decreased survival. And I even see that most recent updated data just showing it still continued. Can you talk a little bit about why you think there is a difference? I know there's ongoing trials, but still interested in kind of why do you think there's a survival difference? Dr. Andreas Obermair:  So Ebony, I hope you don't mind me going back a step. So the LACC study was developed from the LACE trial. So we thought we wanted to reproduce the LACE data/LAP2 data. We wanted to reproduce that in cervix cancer. And people were saying, why do you do that? Like, why would that be different in any way? We recognize that minimally invasive radical hysterectomy is not a standard. We're not going to enroll patients in a randomized trial where we open and do a laparotomy on half the patients. So I think the lesson that really needs to be learned here is that any surgical intervention that we do, we should put on good evidence footing because otherwise we're really running the risk of jeopardizing patients' outcomes. So, that was number one and LACC started two years after LACE started. So LACC started in 2007, and I just wanted to acknowledge the LACC principal investigator, Dr. Pedro Ramirez, who at the time worked at MD Anderson. And we incidentally realized that we had a common interest. The findings came totally unexpected and came as an utter shock to both of us. We did not expect this. We expected to see very similar disease-free and overall survival data as we saw in the endometrial cancer cohort. Now LACC was not designed to check why there was a difference in disease-free survival. So this is very important to understand. We did not expect it. Like, so there was no point checking why that is the case. My personal idea, and I think it is fair enough if we share personal ideas, and this is not even a hypothesis I want to say, this is just a personal idea is that in endometrial cancer, we're dealing with a tumor where most of the time the cancer is surrounded by a myometrial shell. And most of the time the cancer would not get into outside contact with the peritoneal cavity. Whereas in cervix cancer, this is very different because in cervix cancer, we need to manipulate the cervix and the tumor is right at the outside there. So I personally don't use a uterine manipulator. I believe in the United States, uterine manipulators are used all the time. My experience is not in this area, so I can't comment on that. But I would think that the manipulation of the cervix and the contact of the cervix to the free peritoneal cavity could be one of the reasons. But again, this is simply a personal opinion. Dr. Ebony Hoskins: Well, I appreciate it. Dr. Andreas Obermair: Ebony at the end of the day, right, medicine is empirical science, and empirical science means that we just make observations, we make observations, we measure them, and we pass them on. And we made an observation. And, and while we're saying that, and yes, you're absolutely right, the final [LACC] reports were published in JCO recently. And I'm very grateful to the JCO editorial team that they accepted the paper, and they communicated the results because this is obviously very important. At the same time, I would like to say that there are now three or four RCTs that challenge the LACC data. These RCTs are ongoing, and a lot of people will be looking forward to having these results available. Dr. Ebony Hoskins: Very good. In early-stage cervical cancer, the SHAPE trial looked at simple versus radical hysterectomy in low-risk cervical cancer patients. And as well all know, simple hysterectomy was not inferior to radical hysterectomy with respect to the pelvic recurrence rate and any complications related to surgery such as urinary incontinence and retention. My question for you is have you changed your practice in early-stage cervical cancer, say a patient with stage 1B1 adenocarcinoma with a positive margin on conization, would you still offer this patient a radical hysterectomy or would you consider a simple hysterectomy? Dr. Andreas Obermair:  I think this is a very important topic, right? Because I think the challenge of SHAPE is to understand the inclusion criteria. That's the main challenge. And most people simplify it to 2 cm, which is one of the inclusion criteria but there are two others and that includes the depth of invasion. Dr. Marie Plante has been very clear. Marie Plante is the first author of the SHAPE trial that's been published in the New England Journal of Medicine only recently and Marie has been very clear upfront that we need to consider all three inclusion criteria and only then the inclusion criteria of SHAPE apply. So at the end of the day, I think what the SHAPE trial is telling us that small tumors that would strictly fulfill the criteria of a 1B or 1B1 cancer of the cervix can be considered for a standard type 1 or PIVA type 1 or whatever classification we're trying to use will be eligible. And that makes a lot of sense. I personally not only look at the size, I also look at the location of the tumor. I would be very keen that I avoid going through tumor tissue because for example, if you have a tumor that is, you know, located very much in one corner of the cervix and then you do a standard hysterectomy and then you have a positive tumor margin that would be obviously, most people would agree it would be an unwanted outcome. So I'd be very keen checking the location, the size of the tumor, the depths of invasion and maybe then if the tumor for example is on one side of the cervix you can do a standard approach on the contralateral side but maybe do a little bit more of a margin, a parametrial margin on the other side. Or if a tumor is maybe on the posterior cervical lip, then you don't need to worry so much about the anterior cervical margin, maybe take the rectum down and maybe try to get a little bit of a vaginal margin and the margin on the uterus saccals. Just really to make sure that you do have margins because typically if we get it right, survival outcomes of clinical stage 1 early cervix cancer 1B1 1B 2 are actually really good. It is a very important thing that we get the treatment right. In my practice, I use a software to record my treatment outcomes and my margins. And I would encourage all colleagues to be cognizant and to be responsible and accountable to introduce accountable clinical practice, to check on the margins and check on the number on the percentage of patients who require postoperative radiation treatment or chemo radiation. Dr. Ebony Hoskins: Very good. I have so many questions for you. I don't know the statistics in Australia, but here, there's increased rising of endometrial cancer and certainly we're seeing it in younger women. And fertility always comes up in terms of kind of what to do. And I look at the guidelines and, see if I can help some of the women if they have early-stage endometrial cancer. Your thoughts on what your practice is on use of someone who may meet criteria, if you will. The criteria I use is grade 1 endometrioid adenocarcinoma. No myometria invasion. I try to get MRI'd and make sure that there's no disease outside the endometrium. And then if they make criteria, I typically would do an IUD. Can you tell me what your practice is and where you've had success? Dr. Andreas Obermair: So, we initiated the feMMe clinical trial that was published in 2021 and it was presented in a Plenary at one of the SGO meetings. I think it was in 2021, and we've shown complete pathological response rates after levonorgestrel intrauterine device treatment. And so in brief, we enrolled patients with endometrial hyperplasia with atypia, but also patients with grade 1 endometrial adenocarcinoma. Patients with endometrial hyperplasia with atypia had, in our series, had an 85 % chance of developing a complete pathological response. And that was defined as the complete absence of any atypia or cancer. So endometrial hyperplasia with atypia responded in about 85%. In endometrial cancer, it was about half, it was about 45, 50%. In my clinical practice, like as you, I see patients, you know, five days a week. So I'm looking after many patients who are now five years down from conservative treatment of endometrial cancer. There are a lot of young women who want to get pregnant, and we had babies, and we celebrate the babies obviously because as gynecologist obstetricians it couldn't get better than that, right, if our cancer patients have babies afterwards. But we're also treating women who are really unfit for surgery and who are frail and where a laparoscopic hysterectomy would be unsafe. So this phase is concluded, and I think that was very successful. At least we're looking to validate our data. So we're having collaborations, we're having collaborations in the United States and outside the United States to validate these data. And the next phase is obviously to identify predictive factors, to identify predictors of response. Because as you can imagine, there is no point treating patients with a levonorgestrel intrauterine joint device where we know in advance that she's not going to respond. So this is a very, very fascinating story and we got our first set of data already, but now we just really need to validate this data. And then once the validation is done, my unit is keen to do a prospective validation trial. And that also needs to involve international collaborators. Dr. Ebony Hoskins: Very good. Moving on to ovarian cancer, we see patients with ovarian cancer with, say, at least stage 3C or higher who started neoadjuvant chemotherapy. Now, some of these patients are hearing different things from their medical oncologist versus their gynecologic oncologist regarding the number of cycles of neoadjuvant chemotherapy after getting diagnosed with ovarian cancer. I know that this can be confusing for our patients coming from a medical oncologist versus a gynecologic oncologist. What do you say to a patient who is asking about the ideal number of chemotherapy cycles prior to surgery? Dr. Andreas Obermair: So this is obviously a very, very important topic to talk about. We won't be able to provide a simple off the shelf answer for that, but I think data are emerging.  The ASCO guidelines should also be worthwhile considering because there are actually new ASCO Guidelines [on neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer] that just came out a few weeks ago and they would suggest that we should be aiming for R0 in surgery. If we can maybe take that as the pivot point and then go back and say, okay, so what do need to do to get the patient to zero?  I'm not an ovarian cancer researcher; I'm obviously a practicing gynecologic oncologist. I think about things a lot and things like that. In my practice, I would want a patient to develop a response after neoadjuvant chemotherapy. So, if a patient doesn't have a response after two or three cycles, then I don't see the point for me to offer her an operation. In my circle with the medical oncologists that I work with, I have a very, very good understanding. So, they send the patient to me, I take them to the theater. I take a good chunk of tissue from the peritoneum. We have a histopathologic diagnosis, we have a genomic diagnosis, they go home the same day. So obviously there is no hospital stay involved with that. They can start the chemotherapy after a few days. There is no hold up because the chances of surgical complication in a setting like this is very, very low. So I use laparoscopy to determine whether the patient responds or not. And for many of my patients, it seems to work. It's obviously a bit of an effort and it takes operating time. But I think I'm increasing my chances to make the right decision. So, coming back to your question about whether we should give three or six cycles, I think the current recommendations are three cycles pending the patient's response to neoadjuvant chemotherapy because my aim is to get a patient to R0 or at least minimal residual disease. Surgery is really, in this case, I think surgery is the adjunct to systemic treatment. Dr. Ebony Hoskins: Definitely. I think you make a great point, and I think the guideline just came out, like you mentioned, regarding neoadjuvant. And I think the biggest thing that we need to come across is the involvement of a gynecologic oncologist in patients with ovarian cancer. And we know that that survival increases with that involvement. And I think the involvement is the surgery, right? So, maybe we've gotten away from the primary tumor debulking and now using more neoadjuvant, but surgery is still needed. And so, I definitely want to have a take home that GYN oncology is involved in the care of these patients upfront. Dr. Andreas Obermair: I totally support that. This is a very important statement. So when I'm saying surgery is the adjunct to medical treatment, I don't mean that surgery is not important. Surgery is very important. And the timing is important. And that means that the surgeons and the med oncs need to be pulling on the same string. The med oncs just want to get the cytotoxic into the patients, but that's not the point, right? We want to get the cytotoxic into the patients at the right time because if we are working under this precision surgery, precision treatment mantra, it's not only important what we do, but also doing it at the right time. And ideally, I I would like to give surgery after three cycles of neoadjuvant chemotherapy, if that makes sense. But sometimes for me as a surgeon, I talk to my med onc colleagues and I say, “Look, she doesn't have a good enough response to her treatment and I want her to receive six cycles and then we re-evaluate or change medical treatment,” because that's an alternative that we can swap out drugs and treat upfront with a different drug and then sometimes they do respond. Dr. Ebony Hoskins:  I have maybe one more topic. In the area I'm in, in the Washington D.C. area, we see lots of endometrial cancer and they're not grade 1, right? They're high-risk endometrial cancer and advanced. So a number of patients with stage 3 disease, some just kind of based off staging and then some who come in with disease based off of the CT scan, sometimes omental caking, ascites. And the real question is we have extrapolated the use of neoadjuvant chemotherapy to endometrial cancer. It's similar, but not the same. So my question is in an advanced endometrial cancer, do you think there's still a role, when I say advanced, I mean, maybe stage 4, a role for surgery? Dr. Andreas Obermair: Most definitely. But the question is when do you want to give this surgery? Similar to ovarian cancer, in my experience, I want to get to R0. What am I trying to achieve here? So, I reckon we should do a trial on this. And I reckon we have, as you say, the number of patients in this setting is increasing, we could do a trial. I think if we collaborate, we would have enough patients to do a proper trial. Obviously, we would start maybe with a feasibility trial and things like that. But I reckon a trial would be needed in this setting because I find that the incidence that you described, that other people would come across, they're becoming more and more common. I totally agree with you, and we have very little data on that. Dr. Ebony Hoskins: Very little and we're doing what we can. Dr. Obermair, thank you for sharing your fantastic insights with us today on the ASCO Daily News Podcast and for all the work you do to advance care for patients with gynecologic cancer. Dr. Andreas Obermair: Thank you, Dr. Hoskins, for hosting this and it's been an absolute pleasure speaking with you today. Dr. Ebony Hoskins: Definitely a pleasure and thank you to our listeners for your time today. Again, Dr. Obermair's article is titled, “Controversies in the Surgical Management of Gynecologic Cancer: Balancing the Decision to Operate or Hesitate,” and was published in the 2024 ASCO Educational Book. And you'll find a link to the article in the transcript of this episode. Finally, if you value the insights that you hear on the ASCO Daily News Podcast, please take a moment to rate, review and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers: Dr. Ebony Hoskins @drebonyhoskins Dr. Andreas Obermair @andreasobermair Follow ASCO on social media:       @ASCO on Twitter       ASCO on Bluesky   ASCO on Facebook       ASCO on LinkedIn       Disclosures:   Dr. Ebony Hoskins: No relationships to disclose. Dr. Andreas Obermair: Leadership: SurgicalPerformance Pty Ltd. Stock and Ownership Interests: SurgicalPerformance Pty Ltd. Honoraria: Baxter Healthcare Consulting or Advisory Role: Stryker/Novadaq Patents, Royalties, and Other Intellectual Property: Shares in SurgicalPerformance Pty Ltd. Travel, Accommodation, Expenses: Stryker    

Money is simple. The same things occur throughout history time after time. It is like a car going around the block. One time it may be green, another time orange, another time black. After the 16th time it doesn't make any difference what color the car is—you will recognize it. The same goes for money.There may be little change each time an economic event comes around—but after 15 times you learn to recognize what it is. Once we grasp how simple the system is, it becomes easy to make an accurate educated guess what will come next. What is happening now has happened before—and will happen again.

Money is simple. The same things occur throughout history time after time. It is like a car going around the block. One time it may be green, another time orange, another time black. After the 16th time it doesn't make any difference what color the car is—you will recognize it. The same goes for money.There may be little change each time an economic event comes around—but after 15 times you learn to recognize what it is. Once we grasp how simple the system is, it becomes easy to make an accurate educated guess what will come next. What is happening now has happened before—and will happen again.

Missouri Secretary of State Denny Hoskins is defending his decision to reject sports betting emergency rules, saying there isn't an urgent need and also he doesn't want to short circuit public input. STLPR politics correspondent Jason Rosenbaum talks with Hoskins. Later, Rosenbaum joins the show for context and analysis about the future of sports gambling in Missouri.

The Marc Cox Morning Show welcomes Missouri Secretary of State Denny Hoskins to break down the reality behind the sports betting bill and why it's not delivering the promised millions to schools. Hoskins defends his decision not to fast-track the process, pushing back against casino pressure. Marc highlights how the real winners in this legislation are the gambling industry, not Missouri taxpayers.

Denny Hoskins, Missouri Secretary of State On Sports Betting Delays | 2-25-25See omnystudio.com/listener for privacy information.

In this segment, Mark is joined by the Missouri Secretary of State, Denny Hoskins who recently was at the center of delaying the start of sports betting in the state. He and Mark debate the topic and Mark is then joined by Alex Gold, with Kansas City's 610 Sports Radio. He shares his thoughts on the delay as well.